simaomicin alpha(100157-22-0)
- Name: simaomicin alpha
- Synonyms:2H-Xantheno[2',3':6,7][1,3]benzodioxino[4,5-fg]isoquinoline-1,15-dione,7a,8,11,12,13,14-hexahydro-11,14,16,17-tetrahydroxy-9-methoxy-2,3-dimethyl-,(7aa,11b,14a)-(+)-; Antibiotic D 42067a; LL-D 42067a;Simaomicin a
- Molecular Formula:C28H25 N O10
- Molecular Weight:535.4988
- CAS Registry Number:100157-22-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.100157-22-0 simaomicin alpha
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] 
Assessed
SupplierTel:+86-189 8945 5137
Address:Jian Qiao Community, 789 Shenhua Road, Xihu District, Hangzhou, China, 310000
- Contact Suppliers
Other Product
- 3515-59-1/1-benzyl-4-[(5-methoxy-1H-indol-3-yl)methyl]piperidinium chloride
- 299-84-3/FENCHLORPHOS
- 105304-96-9/BISTHEONELLIDE A
- 36211-12-8/Nalpha,Nalpha-dimethyl-N-[(10Z)-3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]tryptophanamide
- 61732-85-2/bamipine hydrochloride
- 88377-29-1/2-Bromo-3-methoxybenzoic acid
- 85283-82-5/1-amino-4-[[3-[(dimethylamino)methyl]phenyl]amino]anthraquinone, compound with methyl hydrogen sulphate (1:1)
- 18046-19-0/3-hydrazinopropionic acid
- 49693-20-1/N,N-bis(2,4,6-tribromophenyl)benzene-1,4-dicarboxamide
- 926-23-8/Bis(isopropylamino)fluorophosphine sulfide
- 7466-43-5/2-cyclohexyl-4-[(2,5-dichlorophenyl)hydrazinylidene]cyclohexa-2,5-dien-1-one
- 108680-74-6/2,7-Naphthalenedisulfonicacid,3-[2-(4-chloro-2-phosphonophenyl)diazenyl]-6-[2-(2,6-dibromo-4-nitrophenyl)diazenyl]-4,5-dihydroxy-
- 82626-01-5/ALPIDEM
- 73374-22-8/3,6-dimethoxy-9-(4-methoxyphenyl)-9H-xanthene-2,7-diol
- 91-81-6/Tripelennamine
- 85586-74-9/4,4'-[1,4-phenylenebis[methylene(ethylimino)]]bis[alpha,alpha-bis[4-(dimethylamino)phenyl]-o-xylene-alpha-ol]
- 518-75-2/CITRININ
- 52025-34-0/5-Amino-2-ethoxypyridine
- 749-48-4/3-Dibenzo(b,e)thiepin-11(6H)-ylidene-N,N-dimethylpropylamine S-oxide
- 100157-22-0/simaomicin alpha
- 64280-48-4/7H-1,4-Dioxino[2,3-c]xanthen-7-one,2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-,(2R,3R)-rel-
- 104564-71-8/4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol - 4-O-beta-D-galactopyranosyl-D-gluconic acid (1:1)
- 24167-79-1/Lithium phosphide(Li(H2P)) (8CI,9CI)
- 2421-28-5/3,3',4,4'-Benzophenonetetracarboxylic dianhydride
- 5836-53-3/N-[4-(5,6-dimethyl-1,3-benzoxazol-2-yl)phenyl]butanamide
- 5559-08-0/4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(3-fluorophenyl)methoxyacetyl]- amino]-3,3-dimethyl-7-oxo-,monosodium salt,(2S,5R,6R)-
- 625-16-1/T-PENTYL ACETATE
- 1309-42-8/Magnesium hydroxide
- 71420-33-2/N-(2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}phenyl)butanamide hydrochloride
- 205923-56-4/CETUXIMAB